News
After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...
An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...
A High Rate of Prescriptions Are Written. The Report examined the number of prescriptions that resulted from patient participation in a Program, concluding that the rate was “high”. In one case, the ...
The opportunity to “ talk to a doctor now ” increases access to care, the drug companies say. But the legislators, and some ...
Several months after a group of senators sent letters to Pfizer and Eli Lilly investigating their respective direct-to-consumer telehealth platforms, the lawmakers are now directing similar ...
Eli Lilly (LLY) revealed a new stipulation regarding its business dealings with telehealth companies Ro and LifeMD (LFMD), ensuring that compounded versions of its GLP-1 weight-loss drugs are not ...
Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro.
Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly clarified that it would not partner with telehealth firms offering compounded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results